Product created by Royal Canin North America fills an unmet need in the veterinary dermatology realm
Royal Canin North America, a company focusing on pet health nutrition, has announced the launch of Skintopic. This new diet was created to help manage canine atopic dermatitis for improved quality of life for dogs suffering from this condition, as a recent clinical trial revealed that precise nutrition can decrease itch and medication reliance in the treatment of atopic dermatitis.1
According to a company release,2 the diet features include support of sensitive skin, improvement of quality of life through itch management, and support of a strong skin barrier and immunity.
"Royal Canin is committed to making a better world for pets by putting the needs of pets at the forefront of scientific innovation," stated Jean-Lin Pelatan, general manager, Royal Canin US Veterinary Business Unit, in the release. "We are proud to introduce Skintopic, a nutritional solution for the management of atopic dermatitis, backed by robust science. We are confident this unique diet will help veterinarians provide better outcomes in atopy management.”2
One in every 10 dogs can be suffering from atopic dermatitis.3-5 In veterinary practices, dermatology cases consist of about 20% or more of a veterinarian's caseload.6 Despite how prevalent the condition is, diagnosis and finding the proper treatment plan for atopic dermatitis can pose a challenge, and owners typically visit a general practitioner various times before being referred to a dermatologist. It was also found that 73% of pet owners who visit their primary care veterinarian more than 3 times for examining their pets' skin condition “reach a tipping point of frustration.”7
Skintopic offers a solution for this dilemma as it’s a clinically proven diet supporting skin health in dogs and featuring the patented Dermauxilium complex, a unique blend of nutrients and antioxidants to help support skin quality and coat health. University of Zurich research in 2022 discovered that after 9 months on Skintopic, 82% of dogs required significantly less medication and 64% of dogs had significantly reduced itch.1
This product will be available in June 2023.
References